Mesothelioma Survey Project

The Asbestos Hotline is Now Launched and Online

Environmental Control Services has announced the official launch of TheAsbestosHotline.com, an informational website about asbestos that is totally free to the public.

Ashland, KY, November 01, 2008 -- Environmental Control Services, Inc. has announced the launch of their new website, TheAsbestosHotline.com. President & CEO, David Runyon has taken over 20 years of experience in the asbestos consulting, testing, and training field and created this very informational website that includes an online tutorial about asbestos, health effects, uses of the mineral, etc. TheAsbestosHotline is totally free to the public.

Mr. Runyon has worked in the asbestos field since 1986 and has extensive experience in the identification of asbestos containing materials, bulk material sampling, air monitoring, abatement design, and abatement project management. He has conducted hundreds of inspections in schools and commercial buildings as well as conducting asbestos awareness training for school system employees since the Asbestos Hazard Emergency Response Act (AHERA) came into effect in 1989. Mr. Runyon also served on the Board of Directors of the West Virginia Environmental Council and was a member of an advisory council that reviewed and made recommendations for the development of the West Virginia State Asbestos Regulations.

TheAsbestosHotline.com also allows users to easily locate asbestos attorneys, abatement contractors, and asbestos inspectors in their state. There can be hundreds or in some cases thousands of licensed asbestos professionals in some states. TheAsbestosHotline.com makes it much easier to find the professional needed. Asbestos Attorneys, Lawyers, Asbestos Contractors, and Asbestos Inspectors can contact TheAsbestosHotline.com directly by phone or online for listing information.

Founder, David Runyon said about TheAsbestosHotline: "We found throughout the years that some people who have worked around asbestos containing materials in schools, commercial buildings and general industry, have at one time or another, been through an asbestos awareness training course. The vast majority of the people in the USA however, still know very little about asbestos. We also found that a lot of these people had only minimal knowledge about it and some had a lot of misconceptions. That's why we developed an online tutorial About Asbestos on TheAsbestosHotline.com."

Contact Information
Environmental Control Services
Dave Runyon
877-508-9887
daver@yoursafeworkplace.com
http://www.theasbestoshotline.com
Asbestos Attorneys, Contractors, and Inspectors may contact them directly to list your company or firm at 877-508-9887

// posted by (hris @ 7:06 PM 0 Comments Links to this post

Ads Running Throughout the City Are Alerting New Yorkers That a Major Cancer is Now Preventable

"So Disfiguring, So Preventable," the Message about Oral Cancer that is Dominating the City.

New York, NY, October 30, 2008 -- Preventing oral cancer is the word on the street in New York City, as scores of people are spotting advertisements that are running on hundreds of city buses, inside and out. Oral cancer, which kills twice as many Americans as cervical cancer, is now especially on the rise in young people, women and non-smokers partly due to what is widely suspected to be an oral sex related increase in exposure to the human papilloma virus (HPV). OralCDx Laboratories, a division of Oral Cancer Prevention International, has launched a bus ad campaign, urging people to visit BrushTest certified dentists for this routine screening test. The BrushTest, often compared to the Pap smear for the prevention of cervical cancer, tells patients if any of the common red and white spots that are found in almost everyone's mouth at one time or another are pre-cancerous and need to be removed, long before they have the chance to develop into cancer.

The ad appears on the outside and inside of 450 MTA buses. Simultaneously, a similar ad jointly placed by OralCDx Laboratories and the American Dental Association is running on over 100 MTA buses.

The bus ads will be running until the end of November, leading into the Greater New York Dental Meeting, taking place at The Javits Center starting on November 28.

Oral cancer, one of the most disfiguring cancers, kills about as many Americans as melanoma and twice as many as cervical cancer. Very few cancers are preventable, and OralCDx is on a mission to let people know that oral cancer has recently joined the short list of preventable cancers. The effectiveness and accuracy of the BrushTest is referenced by both the National Cancer Institute and the ADA, and the test is used by over 30,000 dentists nationwide.

About the BrushTest

OralCDx Laboratories, a division of Oral Cancer Prevention International, Inc., is the worldwide, exclusive provider of the BrushTest, utilizing patented and proprietary tissue sampling and cell analysis systems. The BrushTest is used by dentists and physicians to help prevent oral cancer, a disease that kills as many Americans as melanoma, twice as many as cervical cancer, and is rising among women, young people and non-smokers. Well over 25% of those found to have oral cancer do not use tobacco or abuse alcohol. Recent studies have also shown a link between HPV and an increase in oral cancer.

The BrushTest is taught in the majority of U.S. dental schools and is a covered benefit under Medicare, Medicaid and most private U.S. medical and dental insurance plans. The American Dental Association (ADA), in collaboration with OralCDx Laboratories, has recently embarked on a campaign to inform patients that because of the BrushTest, oral cancer has joined the short list of cancers that can now be stopped, years before they can even start. The accuracy of OralCDx was demonstrated in one of the largest studies in oral medicine ever conducted, performed at 35 academic centers in the U.S., involving nearly 1,000 patients. This study was published as the cover story of the Journal of the American Dental Association and earned OralCDx the ADA's prestigious Seal of Acceptance.

For more information on the OralCDx BrushTest, call (877) 672-5722 or visit www.BrushTest.com.

Contact Information

OralCDx Laboratories
Sharon Golubchik
845-368-7451
gsharon@cdxlabs.com
www.oralcdx.com

// posted by (hris @ 1:56 PM 0 Comments Links to this post

LegalView Informs Mesothelioma Blog Readers with Details on Asbestos: Silent Killer of American Veterans Dating Back to World War II

LegalView informed mesothelioma blog readers of a silent killer of American soldiers and veterans besides traumatic brain injury (TBI). Mesothelioma cancer has likely affected thousands of American veterans, even dating back to World War II navy veterans.

Denver, CO, August 17, 2008 -- LegalView, the most comprehensive legal resource available on the Internet, unveiled details of a "silent killer" of American veterans that dates back to World War II. Asbestos fibers and dust may have been silently killing veterans returning home from American-fought wars, and has long been overlooked, according to veteran and book author William S. Burton Sr. Currently, many scientists and researchers have deemed traumatic brain injury (TBI) to be the "signature injury" of the recent war, but veterans also suffer from mesothelioma cancer caused by the inhalation of asbestos.

According to Burton, veterans, especially navy veterans from World War II, have had difficulties proving their asbestos-induced conditions to the Department of Veterans Affairs (VA). Veterans as well as those suffering from the cancer are encouraged to locate a mesothelioma law firm that can provide a plethora of experienced mesothelioma attorneys to choose from.

Mesothelioma cancer is caused by inhaling asbestos fibers, which were mined throughout the world in the 20th century. Tremolite, which is found in asbestos, caused fibers being inhaled to line the inside of the lung causing the deadly form of cancer that can spread to other parts of the body. While much is being done to find out about mesothelioma treatment, there are no known cures and very few treatments that can offer an increased survival rate. Veterans who suffer from this lung condition should seek medical attention and consult a mesothelioma attorney to learn about receiving medical disability and compensation claims for war-related conditions/illnesses.

For more on mesothelioma cancer visit LegalView's homepage. On this site, find several other various categories to navigate through and locate information on legal topics such as the faulty Zimmer Durom cup or the tendonitis-inducing Levaquin. Also learn the latest on the Viapro recall.

The failing Durom cup hip socket from Zimmer Holdings has stopped being manufactured while hundreds of physicians claim the Durom cup risks have caused failing hip components among some patients, which would likely be cause for an additional hip replacement surgery. The faulty hip socket has already been implanted into approximately 12,000 patients since the components release in 2006.

Levaquin, which is an antibiotic belonging to the fluoroquinolones drug group, was recently issued the harshest label possible by the U.S. Food and Drug Administration (FDA). The black box label is a warning for physicians that the drug includes serious side effects such as the increased risk of tendonitis or tendon rupture among patients. Individuals taking Levaquin are encouraged to contact a pharmaceutical attorney to learn about the details of a Levaquin class action lawsuit.

The ongoing complications associated with Viapro were discovered after an internal investigation and test by the FDA that found an undeclared ingredient in the drug. Viapro, which treats erectile dysfunction (ED) and sexual impotency, has been recalled, but patients may still suffer from the Viapro side effects. Those who are at risk are those also consuming medications containing nitrates, which can be found in high blood pressure, high cholesterol, heart disease and diabetes medications.

About LegalView:

LegalView.com is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www.LegalView.com/.

Contact Information
LegalView
Katie Kelley
720-771-3246
press-releases@legalview.com
www.legalview.com

// posted by (hris @ 11:37 PM 0 Comments Links to this post

LegalView Blog Announces Recruitment of Mesothelioma Victims for New Clinical Trial Combining Chemotherapy and Radiation Treatments

LegalView made available the details of a new clinical trial, which will test chemotherapy and radiation methods rather than surgery as a treatment among mesothelioma patients. Victims of mesothelioma cancer are currently being recruited for the study, which will likely last 13 weeks.

Denver, CO - July 12, 2008 -- LegalView, the most comprehensive legal resource available on the Web, released details of a newly advertised clinical trial that will target radiation and chemotherapy treatments rather than surgery for mesothelioma patients. The study is for individuals suffering from malignant pleural mesothelioma, which is often considered the most deadly form of mesothelioma cancer. The trial will take approximately 13 weeks and will involve exploratory surgery as well as chemotherapy and radiotherapy, which will be administered directly into the affected area.

Mesothelioma cancer is caused by the inhalation of asbestos fibers and dust, which can occur anywhere asbestos has been previously used, although it is most commonly found in insulation within the construction industry. Individuals who have been affected by mesothelioma cancer are advised to seek out a mesothelioma law firm that can provide victims with a better understanding of the details of a potential mesothelioma lawsuit. An experienced law firm will also provide a plethora of mesothelioma lawyers to deal with the specifics of an individual's asbestos-related case.

The new clinical trial aims to find a successful alternative treatment to surgery. Currently, mesothelioma cancer has a grim prognosis, as it is usually not successfully treatable and most often the cancerous portions of the lung are removed via a surgical procedure, which doesn't commonly provide a prolonged life for victims. Additionally, according to the details of the study, surgery "may even lead to a worsened pulmonary function" among patients. For more information on developing litigation related to mesothelioma and asbestos, individuals should locate a mesothelioma attorney who can provide legal consultation on the details of an individual victim's lawsuit.

For information on locating an experienced lawyer, visit LegalView's homepage, which also offers additional information on an array of legal topics including the heavily discussed pharmaceutical controversies that have recently threatened patients. For example, prescription drugs such as Levaquin, Avandia and Chantix have become hot topics in many news reports for the alleged side effects and potential risks associated with each drug.

Levaquin is an anti-bacterial prescription drug that is part of the fluoroquinolone drug family. Levaquin is used for an array of conditions ranging from urinary tract infections to bronchitis to gonorrhea and Chlamydia to pneumonia. According to several scientific studies recently released, consumption of the drug may lead to Levaquin-induced Achilles tendonitis among patients who take the drug for short- to long-term periods of time. One study published in the Journal of the American Board of Family Medicine suggested that patients who had taken the drug anywhere from 6 months to two years and prior may even be at risk for the Levaquin tendon rupture. Additionally Cipro, another of the fluoroquinolone drugs, has also been found to pose a potential risk for tendonitis and tendon rupture and has thus been given a "black box" Cipro FDA warning. The "black box warning is the strongest warning the FDA can put on a drug.

Finally, Chantix, one of the most recently released prescription drugs, is used to aid patients attempting to quit smoking. In late 2007, hundreds of patients of the smoking-cessation drug had reported unusual Chantix side effects that included mood swings, erratic behavior, depression, suicidal thoughts and tendencies. An additional 37 cases of suicide among Chantix patients had also been reported to the FDA, according to an FDA Public Health Advisory from 2008. To learn more about these issues as well as many others, visit the LegalView homepage.

About LegalView:
LegalView.com is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www.LegalView.com/.

CONTACT INFORMATION
Katie Kelley
LegalView
720-226-6613

Alan Haburchak
legalView
720-226-6613

// posted by (hris @ 10:57 PM 0 Comments Links to this post

John Wayne Cancer Institute Receives Grant to Study Long-term Health Effects of Traumatic Brain Injuries

Research Will Focus on Relationship of Concussion, Pituitary Hormonal Failure and Quality of Life in Retired National Football League Players

SANTA MONICA, Calif.-- July 02, 2008--The John Wayne Cancer Institute at Saint John's Health Center announced today that it has received a grant from the National Operating Committee on Standards for Athletic Equipment to study pituitary hormonal failure (hypopituitarism) in retired football players.

The research, which will be conducted in collaboration with the University of North Carolina's (UNC) Department of Exercise and Sport Science, and the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, will be directed by Daniel F. Kelly, MD, director of the Neuro-Endocrine Tumor Center at the John Wayne Cancer Institute, and Kevin M. Guskiewicz, PhD, chairman of the Department of Exercise and Sport Science at UNC.

In a cohort of retired National Football League (NFL) players, the study will examine the relationship between the number of concussions sustained in players' NFL careers, and their subsequent pituitary hormonal function and post-retirement quality of life. The investigators hypothesize that players sustaining multiple concussions are at increased risk of developing pituitary hormonal dysfunction which may in turn contribute to problems of obesity, fatigue, impaired metabolism, depression, sexual dysfunction and a general poor quality of life.

According to Dr. Kelly, the new study will focus on a relatively unexplored area of traumatic brain injury (TBI)-the potential correlation between recurrent concussions and pituitary hormonal dysfunction. More than 1.2 million Americans sustain a TBI annually, the majority of which are cerebral concussions. Repeat concussions have been shown to be a risk factor for neurodegenerative dementing disorders, including mild cognitive impairment and Alzheimer's Disease. However, little is known about the impact of single or multiple concussions on hormonal function and quality of life. Only in the sport of boxing, have a few small studies shown that boxers are at increased risk of developing pituitary failure. In contrast, it is well known that a single severe head injury can lead to pituitary damage and hormonal abnormalities in up to one third of individuals.

The pituitary is a small bean-shaped gland located immediately below the brain and behind the nasal cavity in the skull base; it is connected to the brain by the thin delicate vascular pituitary stalk. Weighing less than one gram, the pituitary is often called the "master gland" since it controls the secretion of the body's hormones. These essential substances when released by the pituitary into the blood stream have a broad range of effects on growth and development, sexuality and reproductive function, metabolism, the response to stress and overall quality of life.

"This research is long overdue," Dr. Kelly said. "Millions of young people and professional athletes participate in sports that put them at risk of concussion; not just football, but also hockey, rugby, soccer, baseball and basketball. We need to know more about how these so-called "minor head injuries" impact their lives in subsequent years, and in particular, whether multiple concussions can lead to pituitary hormonal failure and poor quality of life."

Using the database of the Center for the Study of Retired Athletes at University of North Carolina and in cooperation with the National Football League Players' Association, 90 study participants will be categorized based on the number of concussions they sustained during their NFL career. The retired players will then be assessed utilizing pituitary hormonal blood tests, body composition testing and neurobehavioral, quality of life and sexual function surveys. Retirees found to be deficient in any hormones such as thyroid, testosterone or growth hormone will be treated with physiological replacement doses of the appropriate hormone and will then have repeat quality of life testing. Hormonal testing assays will be conducted by the General Clinical Research Center at Harbor-UCLA Medical Center under the direction of Professor Christina Wang, an endocrinologist and a study co-investigator.

"The problem of sports-related concussions is increasingly recognized as a major contributor to long-term disability in many retired athletes," said Bob Klein, vice president at Saint John's Health Center and a ten-year NFL veteran with the Los Angeles Rams and San Diego Chargers. "However, the potential impact of concussions on quality of life is not well understood. This research will fill that gap in our knowledge. I have spoken with many of my former colleagues in the NFL, and they share my belief in the critical importance of this study."

The Neuro-Endocrine Tumor Center (www.neuro-endo.org) is housed at Saint John's Health Center and the John Wayne Cancer Institute in Santa Monica, California. The Center's focus of activities is the treatment of pituitary tumors, brain tumors, and other neuro-endocrine disorders including pituitary hormonal deficiencies.

The Center for the Study of Retired Athletes at the University of North Carolina works in close affiliation with the National Football League Players Association. Since 2001, the Center has been investigating a spectrum of physical and mental disabilities common to retired athletes. The research team will begin work in July 2008, with initial research results expected in 2010.

Since its founding in 1942 by the Sisters of Charity of Leavenworth, Saint John's Health Center has been providing the patients and families of Santa Monica, West Los Angeles and ocean communities with compassionate, advanced medical care. Saint John's provides a spectrum of treatment and diagnostic services with distinguished areas of excellence in cancer care, cardiac care, orthopedics and women's health. Saint John's Health Center is also dedicated to bringing to the community the most innovative advances in technology and patient care available in a healing environment.

Since 1981, the John Wayne name has been committed by the Wayne family to groundbreaking cancer research in memory of the much-loved actor who died of cancer. The John Wayne Cancer Institute has received worldwide acclaim for advances in understanding the disease, focusing on melanoma (skin cancer), breast, prostate, colon, pancreatic, lung and liver cancer, as well as lymphoma and leukemia. With its unique ability to rapidly turn scientific breakthroughs into innovative approaches to treatment and early detection, JWCI provides immediate hope to cancer patients from around the globe.
Contacts

Saint John's Health Center
Greg Harrison, 310/829-8010
858/472-5560 (cell)
gregory.harrison@stjohns.org

// posted by (hris @ 11:17 PM 0 Comments Links to this post